Drug makers Glenmark, Strides Pharma and Cipla are recalling products in the US, due to manufacturing issues. As per the latest Enforcement Report issued by the US Food and Drug Administration (US FDA), New Jersey-based Glenmark Pharmaceuticals is recalling over 72,000 units of blood pressure lowering drugs due to packaging issues.

The USFDA noted in its report that the company, a subsidiary of a Mumbai-based drug firm, is recalling the affected lot due to blister package issues. The lot was produced at Glenmark's Pithampur (Madhya Pradesh) based manufacturing facility.

Bengaluru-based Strides Pharma Science is recalling 1,032 bottles of Prednisone tablets, a medication used to treat many conditions including asthma, allergic reactions, arthritis and inflammatory bowel diseases, among others. The affected lot was produced by Strides Pharma Science and marketed in the US by New Jersey-based Strides Pharma.

Cipla is recalling 7,992 bottles of Difluprednate Ophthalmic Emulsion, used to treat swelling and pain after eye surgery, in the US market.

There were complaints regarding "defective container closure."